`:
`In W /
`15t80439 - GAU1t651
`
`Application Number
`
` k
`
`Filing Date
`2016-06-13
`First Named Inventor Inge Bruheim
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`
`| AKBM-14409/US-13lCON
`
`
`
`—l—l—l4;(A)N
`
`—l
`
`—l
`
`|\JO
`
`|\J
`
`
`
`a-nnnnnnvv—|CCD0"hh(.0OtoUIM—|'sl—|O:0')h030')MonMond0')"-44:-dwJ:-—\0')00M‘4‘4CD0')—\Mfi0')fiM"-4gC!)(.001fi3Ln"-4Non"-4NN"-4
`
`‘
`
`OC) d '_\ L71m.4DO0')
`
`EFS Web 2.1.1?
`
`1996—08—14
`
`1 992—02—25
`
`1994—07—1 9
`
`1997—07—08
`
`2003—09—05
`
`2003—10—31
`
`1997—08—05
`
`2005—05—20
`
`1992—01—17
`
`1986—12—11
`
`2001—06—12
`
`
`
`HLORINE ENG CORP
`TD
`
`HLORINE ENG CORP
`TD
`
`KEDA SHOKKEN KK
`
`IPPON OIL & FATS CO
`
`
`
`REEN CROSS CORP
`
`HLORINE ENG CORP
`
`LECTRIC IND CO LTD
`
`HISEIDO CO LTD;
`IPPON SUISAN
`‘ ISHA LTD.
`
`NOW BRAND MILK
`'ROD CO LTD
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0401
`
`page 0401
`
`
`
`

`

`
`:
`In W /
`15I80439 - GAU1I651
`
`Application Number
`
` k
`
`Filing Date
`2016-06-13
`First Named Inventor Inge Bruheim
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`
`| AKBM-14409/US-13lCON
`
`
`
`m|\J|\J|\Jo4:mN
`|\J|\J|\J|\J|\J
`
`m _.
`
`mN
`
`EFS Web 2.1.1?
`
`2003—01—08
`
`NITIKA LTD
`
`oooooooooooooooo9’9’9’9’9‘9’9’9’wwMoM—\ooN—\noa:4:4s4sacoanotoU1anno(.0oo-4go:onon—\a-~ig-~iononno4:-wcocom—\N
`
`oo9’oonno A wan
`
`‘
`
`‘
`
`oo54'_\ §U1U‘I
`
`2003—02—2 1
`
`2003—05—21
`
`2005—09—1 5
`
`2006—03—1 6
`
`2006—03—30
`
`2006—10—26
`
`2006—1 1—24
`
`2006—12—07
`
`2007—05—24
`
`:5o'7"MEo.p.
`
`2007—09—27
`
`
`
`v. UNTORY LTD
`
`NOW BRAND MILK
`'ROD CO LTD
`
`IPPON SUISAN
`‘ ISHA LTD
`
`IROSE YUKIHIRO
`UJI CHEM IND CO LTD
`
`v. UNTORY LTD
`
`IROSE YUKIHIRO
`
`BR ISRAELI
`: IOTECH NOLOGY
`' ESEARCH LTD
`
`IROSE YUKIHIRO
`
`NOW BRAND MILK
`'ROD CO LTD
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0402
`
`page 0402
`
`
`
`

`

`
`:
`In W /
`15t80439 - GAU1t651
`
`Application Number
`
` k
`
`Filing Date
`2016-06-13
`First Named Inventor Inge Bruheim
`
`
`
`IN FORMATION DISCLOSU RE
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`
`
`| AKBM-14409/US-13lCON
`
`0000
`
`004:.
`
`000'1
`
`mmmmo«3co-4on
`
`4:.
`
`4:-4:-N_n
`
`4:.00
`
`
`
`EFS Web 2.1.17
`
`986l06082
`
`990l05765
`
`993l24142
`
`997l38585
`
`‘‘‘‘oooMoooo999“'4uNNflcoU1w«I0':U!oo4:coonon
`
`997l39759
`
`998l34498
`
`999l39589
`
`0‘
`
`1971—01—06
`
`RGUCH KOV
`
`
`
`1986—10—23
`
`1990—05—31
`
`1993—12—09
`
`1997—10—23
`
`1997—10—30
`
`1998—08—1 3
`
`1999—08—12
`
`2000—04—27
`
`2000—05—1 1
`
`2000—07—06
`
`AT—CON RADGIVEND =
`
`NGENIQRFIRMA AIS
`
`IKALSEN
`
`'HAIRSON MEDICAL A:
`
`HE UNIVERSITY OF
`.RITISH COLUMBIA
`
`: RIGHAM AND
`OMEN'S HOSPITAL
`
`: IOZYME SYSTEMS
`
`‘ LOISE
`
`NIV SHERBROOKE
`
`‘ ISHA, LTD
`
`IPPON SUISAN
`
`'HAIRSON MEDICAL
`NC.
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0403
`
`page 0403
`
`
`
`

`

`IN FORMATION DISCLOSU RE
`
`
`15180439 - GAL/11651
`ID 313/ /
`k
`:
`
`Application Number
`
`
`Filing Date
`2016-06-13
`First Named Inventor Inge Bruheim
`
`
`
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Examiner Name Attorney Docket Number
`Art Unit
`
`| AKBM-14409/US-13/CON
`
`' 002/ 1 02394
`
`' 003/01 1873
`
`EPTUNE
`ECHNOLOGIES &
`
`EPTUNE
`ECHNOLOGIES &
`: IORESSOURCES INC.
`
`' 005/037848
`
`NZYMOTEC LTD.
`
`' 005/038037
`
`NZYMOTEC INC.
`
`' 007/080514
`
`RILL AIS
`
`' 007/080515
`
`‘ KER BIOMARINE ASA
`
`' 007/ 1 08702
`
`2007—09—27
`
`‘ KER SEAFOODS
`
`If you wish to add additional Foreign Patent Document citation information please click the Add button
`
`NON-PATENT LITERATURE DOCUMENTS
`
`Remove
`
`T5
`
`
`
`OLDING AS
`
`
`
`
`
`
` Include name of the author (in CAPITAL LETTERS), title of the article (when appropriate), title of the item
`
`
`
`
`
`(book, magazine, journal, serial, symposium, catalog, etc), date, pages(s), volume-issue number(s),
`publisher, city and/or country where published.
`
`‘ NDO and HATANO, 1988, “Isolation of apolipoproteins from carotenoid—carrying lipoprotein in the serum of chum
`.almon, Oncorhynchus keta", J. Lipid Research, 29: 1264—1271
`
`‘ OI et al., 2003, "Astaxanthin limits exercise—induced skeletal and cardiac muscle damage in mice", Antioxidants &
`edox Signaling, 5(1): 139—44
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0404
`
`page 0404
`
`

`

`
`
`i
`
`i
`
`=
`
`
`lg W /
`15180439 - GAU: 1651
`
`,
`'.-
`Application Number
`
`
`
`
`Filing Date
`2016-06-13
`First Named Inventor
`Inge Bruheim
`
`Ar, Unit
`|
`
`
`
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`I AKBM-14409/US-13lCON
`
`: RITTON, 1985, “General Carotenoid Methods”, Methods in Enzymology, Vol 111, pp. 113—149
`
`ALDER, 2006, "n—3 polyunsaturated fatty acids, inflammation, and inflammatory diseases”, Am. J. Clin. Nutr., 83:
`5053
`
`HAREST et al., 2001, “Astaxanthin Extraction from Crawfish Shells by Supercritical CO2 with Ethanol as Cosolvent”,
`. Aquatic Food Product Technology, 10(3): 79-93
`
`HEN and MEYERS, 1982, “Extraction of Astaxanthin Pigment from Crawfish Waste Using a Soy Oil Process”, J.
`ood Sci, 47: 892-896
`
`LARKE, 1980, “The Biochemical Composition of Krill, Euphausia superba dana,from South Georgia”, J. Exp. Mar.
`iol. Ecol, 43: 221-236
`
`ZECZUGA, 1974, "Comparative Studies of Carotenoids in the Fauna of the Gullmar Fjord (Bohuslan, Sweden). l|.
`rustacea: Eupagurus bernhardus, Hyas coarctatus and Upogebia deltaura", Marine Biology, 28: 95-98
`
`IE RITTER and PURCELL, 1981, “Carotenoid Analytical Methods”, Carotenoids as Colorants and Vitamin A
`' recursors: Technological and Nutritional Applications, pp 815-882
`
`I EUTCH, 1995, "Menstrual pain in Danish women correlated with low n—3 polyunsaturated fatty acid intake", Eur. J.
`lin. Nutr., 49(7): 508-16
`
`I IEZ et al., 2003, "The role of the novel adipocyte—derived hormone adiponectin in human disease”, Eur. J.
`ndocrinol., 148(3): 293-300
`
`LLINGSEN et al., 1987, "Biochemistry of the autolytic processes in Antarctic krill post mortern. Autoproteolysis."
`iochem. J. 246, 295—305
`
`—l N
`
`
`00
`
`MODI, 1978, “Carotenoids: Properties and Applications", Food Technology, 32(5): 38
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0405
`
`page 0405
`
`

`

`
`
`:
`'.-
`Application Number
`
`i
`
`i
`
`=
`
`
`lg W /
`15i80439 - GAU: i651
`
`
`
`
`Filing Date
`2016-06-13
`First Named Inventor
`Inge Bruheim
`
`Ar, Uni,
`|
`
`
`
`
`INFORMATION DISCLOSURE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`Examiner Name
`
`Attorney Docket Number
`
`I AKBM-14409/US-13/CON
`
`4:.
`
`ELIX—VALENZUELA et al., 2001, "Supercritical CO2IEthano| Extraction of Astaxanthin from Blue Crab (Callinectes
`apidus) Shell Waste", Journal of Food Process Engineering, 24: 101-112
`
`
`
`—l
`
`—l U'i
`
`|\J|\J—lO'Nl
`
`—|
`
`|\JN
`
`|\J00
`
`|\J4:.
`
`EFS Web 2.1.17
`
`OX and SCHEER, 1941, "Comparative Studies of the Pigments of Some Pacific Coast Echinoderms", The Biological
`.ulletin, 441—455
`
`EUSENS et al., 1994, “Long—term effect of omega—3 fatty acid supplementation in active rheumatoid arthritis. A 12—
`onth, double-blind, controlled study", Arthritis Rheum, 37(6): 824—9
`
`ILCHRIST and GREEN, 1960, "The Pigments of Anemia", Proceedings of the Royal Society, Series B Biological
`ciences, Vol 152 No. 946, pp 118—136
`
`OODWIN and SRISUKH, 1949, "Some Observations on Astaxanthin Distribution in Marine Crustacea", Depaltment
`f Biochemistry, University of Liverpool, pp. 268-270
`
`ULYAEV and BUGROVA, 1976 "Removing fats from the protein paste “Okean”. Konservnaya l Ovoshchesushil’naya
`'romyshlennost, (4), 37—8
`
`ARDARDO‘I‘I’IR and KINSELLA, 1988, "Extraction of Lipid and Cholesterol from Fish Muscle with Supercritical
`luids” Journal of Food Science, 53(6): 1656—1658
`
`ntemational Search Report and Written Opinion for PCT/lBZO10/000512; dated 2010—06—24
`
`NTERNATIONAL AQUA FEED, 2006, Vol. 9
`
`ntemational Search Report and Written Opinion for PCT/GB2008/002934, Dated 2009—03—11
`
`ntemational Search Report for PCT/820071000098, dated: 2007—06—26
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0406
`
`page 0406
`
`
`
`

`

`
`
`
`15180439 - GAU: 1651
`In W /
`k
`I
`
`Application Number
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2016-06-13
`First Named Inventor
`Inge Bruheim
`
`
`Art Unit |
`Examiner Name
`
` Attorney Docket Number
`
`I AKBM-14409/US-13/CON
`
`
`
`
`
`|\JUI
`
`TOH et al., 2007; "Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of
`besity and human obese subjects", Arteriosclerosis, Thrombosis, and Vascular Biology; 27(9): 1918-1925
`
`OHNSON et al., 1978, “Simple Method for the Isolation of Astaxanthin from the Basidiomycetous Yeast Phaffia
`odozyma", Applied and Environmental Microbiology, 35(6): 1155-1159
`
`OLAKOWSKA, 1989, "Krill lipids after frozen storage of about one year in relation to storage time before freezing",
`ie Nahrung Food, 33(3): 241—244
`
`RIS—ETHERTON et al., 2002, “Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease",
`irculation, 106:2747-2757
`
`|\J0')
`
`N-..4
`
`000000|\J|\JNO(.0CO
`
`—|
`
`00
`
`004k00
`
`00UI
`
`RISTENSEN et al., 1989, "Dietary supplementation with n—3 polyunsaturated fatty acids and human platelet function:
`: review with particular emphasis on implications for cardiovascular disease", J. Intern. Med. Suppl. 731:141—50
`
`UNESOVA et al., 2006, “The influence of n—3 polyunsaturated fatty acids and very low calorie diet during a short-term
`eight reducing regimen on weight loss and serum fatty acid composition in severely obese women", Physiol Res; 55
`1):63—72
`
`AIGHT et al., 1999, "F2—isoprostane evidence of oxidant stress in the insulin resistant, obese Zucker rat: effects of
`itamin E", Eur. J. Pharmacol. 377(1): 89—92
`
`AMBERTSON and BRAEKKAN, 1971, “Method of Analysis of Astaxanthin and its Occurrence in some Marine
`'roducts," J. Sci. Food. Agr., Vol 22(2): 99-101
`
`IBBY et al., 2006, “Inflammation and Atherothrombosis: From Population Biology and Bench Research to Clinical
`'ractice”, J. Amer. Coll. Card, 48 (9, Suppl. A): A33—A46
`
`OPEZ et al., 2004, "Selective extraction of astaxanthin from crustaceans by use of supercritical carbon dioxide",
`alanta, 64: 726—731
`
`ANDEVILLE, 1991, "Isolation and Identification of Carotenoid Pigments, Lipids and Flavor Active Components from
`'aw Commercial Shrimp Waste", Food Biotechnology, 5(2): 185-195
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0407
`
`page 0407
`
`

`

`
`
`
`15i80439 - GAU: i651
`In W /
`k
`i
`
`Application Number
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2016-06-13
`First Named Inventor
`Inge Bruheim
`
`
`Art Unit |
`Examiner Name
`
` Attorney Docket Number
`
`I AKBM-l4409/US—13/CON
`
`
`
`
`
`EYERS and BLIGH, 1981, “Characterization of Astaxanthin Pigments from Heat-Processed Crawlish Waste", J.
`gric. Food Chem_, 29: 505-508
`
`EYERS, 1977, "Using Crustacean Meals and Carotenoid—Fortified Diets", Feedstuffs, Vol. 49(19)
`
`EYERS, 1994, "Developments in world aquaculture, feed formulations, and role of carotenoids", Pure & Appl. Chem,
`ol. 66(5): 1069-1076
`
`ILLS et al., 1989, “Dietary N—6 and N-3 fatty acids and salt-induced hypeltension in the borderline hypertensive rat",
`ipids, 24(1): 17—24
`
`OATES and VAN BENTEM, 1990, “Separating out the value”, Food Science and Technology Today, 4(4): 213—214
`
`0000"-l0')
`
`00CO
`
`4:.4:-4:-monN—-o«3
`4:-4:-4:-014k
`
`4:.0')
`
`IKOLAEVA, 1967 “Amino acid composition of protein—coagulate in krill", VNIRO, 63:161-4
`
`' HLEGER, et al. (2002) “lnterannual and between species comparison in the lipids, fatty acids, and sterols of
`‘ ntarctic krill from the US AMLR Elephant Island survey area: 1997 and 1998". Comp Biochem Physiol 1313:733—747
`
`'OPP—SNIJDERS et al., 1987, ”Dietary supplementation of omega—3 polyunsaturated fatty acids improves insulin
`ensitivity in non-insulin—dependent diabetes", Diabetes Res. 4(3): 141—?
`
`.ACHINDRA, 2006, “Recovery of carotenoids from shrimp waste in organic solvents”, Waste Management, 26:
`092-1098
`
`AETHER et al., 1986, ”Lipids of North Atlantic krill", J Lipid Res, 27(3):274—85.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0408
`
`page 0408
`
`

`

`
`
`
`lg W /
`15I80439 - GAU: I651
`
`i
`
`=
`
`i
`
`:
`:—
`Application Number
`
`IN FORMATION DISCLOSU RE
`STATEMENT BY APPLICANT
`
`( Not for submission under 37 CFR 1.99)
`
`
`Filing Date
`2016-06-13
`First Named Inventor
`Inge Bruheim
`
`Art Unit
`|
`
`
`
`Examiner Name
`
`Attorney Docket Number
`
`|AKBM-14409/US-13/CON
`
`
`.OMIYA, 1982, “Yellow lens' eyes of a stomiatoid deep—sea fish, Malacosleus niger”, Proc. R. Soc. Land, 215:
`
`
`
`
`
`.HAHIDI et al., 1998, ”Carotenoid Pigments in Seafoods and Aquaculture" Critical Reviews in Food Science, 38(1):
`
`I
`
`IMOPOULOS, 1991, "Omega-3 fatty acids in health and disease and in growth and development", Am. Clin. Nutr.
`u4.438—63
`
`If you wish to add additional non-patent literature document citation information please click the Add button
`
`EXAMINER SIGNATURE
`
`Examiner Signature
`
`*EXAMINER: Initial if reference considered, whether or not citation is in conformance with MPEP 609. Draw line through a
`citation if not in conformance and not considered.
`Include copy of this form with next communication to applicant.
`
`1 See Kind Codes of USPTO Patent Documents at www.USPTO.GOV or MPEP 901.04. 2 Enter office that issued the document, by the two-letter code (WIPO
`Standard ST.3). 3 For Japanese patent documents, the indication of the year of the reign of the Emperor must precede the serial number of the patent document.
`4 Kind of document by the appropriate symbols as indicated on the document under WIPO Standard ST.16 if possible. 5 Applicant is to place a check mark here if
`English language translation is attached.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0409
`
`page 0409
`
`

`

`
`
`
`
`INFORMATION DISCLOSURE
`
`STATEMENT BY APPLICANT
`
`_
`_
`( Not for submissmn under 37 CFR 1.99)
`
`Art Unit
`
`Examiner Name
`
`Attorney Docket Number
`
`I AKBM-14409/US-13/CON
`
`
`
`I
`:—
`Application Number
`
`i
`
`i
`
`=
`
`
`lg W /
`15180439 - GAU: 1651
`
`
`Filing Date
`2016-06-13
`
`
`
`First Named Inventor Inge Bruheim
`I
`
`
`
`Please see 37 CFR 1.97 and 1.98 to make the appropriate selection(s):
`
`CERTIFICATION STATEMENT
`
`That each item of information contained in the information disclosure statement was first cited in any communication
`from a foreign patent office in a counterpart foreign application not more than three months prior to the filing of the
`information disclosure statement. See 37 CFR 1.97(e)(1).
`
`OR
`
`That no item of information contained in the information disclosure statement was cited in a communication from a
`
`foreign patent office in a counterpart foreign application, and, to the knowledge of the person signing the certification
`after making reasonable inquiry, no item of information contained in the information disclosure statement was known to
`any individual designated in 37 CFR 1.56(c) more than three months prior to the filing of the information disclosure
`statement. See 37 CFR 1.97(e)(2).
`
`El
`
`See attached certification statement.
`
`The fee set forth in 37 CFR 1.17 (p) has been submitted herewith.
`
`X A certification statement is not submitted herewith.
`
`SIGNATURE
`
`A signature of the applicant or representative is required in accordance with CFR 1.33, 10.18. Please see CFR 1.4(d) for the
`form of the signature.
`
`This collection of information is required by 37 CFR 1.97 and 1.98. The information is required to obtain or retain a benefit by the
`public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR
`1.14. This collection is estimated to take 1 hour to complete, including gathering, preparing and submitting the completed
`application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you
`require to complete this form andlor suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S.
`Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND
`FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria,
`VA 22313-1450.
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0410
`
`page 0410
`
`
` NamelPrint
`Signature
`2016—06—13
`
`
`
`

`

`Receipt date: 06/13/2016
`
`ALL REFERENCES CONSIDERED EXCEPT WHERE LINED THROUGH.
`
`/D.W./
`
`1518043994131 1651
`
`Privacy Act Statement
`
`
`The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the
`attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised
`that:
`(1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited
`is voluntary; and (3) the principal purpose for which the information is used by the US. Patent and Trademark Office is to
`process and/or examine your submission related to a patent application or patent.
`If you do not furnish the requested
`information, the U.S. Patent and Trademark Office may not be able to process andr'or examine your submission, which may
`result in termination of proceedings or abandonment of the application or expiration of the patent.
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act
`(5 U.S.C. 552) and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the
`Department of Justice to determine whether the Freedom of Information Act requires disclosure of these record 5.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a
`court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement
`negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a
`request involving an individual, to whom the record pertains, when the individual has requested assistance from the
`Member with respect to the subject matter of the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for
`the information in order to perform a contract. Recipients of information shall be required to comply with the
`requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records
`may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant
`to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of
`National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or
`his/her designee, during an inspection of records conducted by GSA as part of that agency's responsibility to
`recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and
`2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this
`purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make
`determinations about individuals.
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of
`the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record
`may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in
`an application which became abandoned or in which the proceedings were terminated and which application is
`referenced by either a published application, an application open to public inspections or an issued patent.
`
`9.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law
`enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.
`
`
`
`
`
`
`
`EFS Web 2.1.17
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0411
`
`page 0411—
`
`

`

`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BIB DATA SHEET
`
`Page 1 of 1
`
`UNITED STATES DEPARTIVEENT OF COIVIIVIERCE
`United States Patent and Trademark Office
`Address: COMMISSIONER FOR PATENTS
`PO. Box 1450
`Alexandria1 Virginia 22313-1450
`www.uspto.gov
`
`CONFIRMATION NO. 4687
`
`SERIAL NUMBER
`15/180,439
`
`FILINS‘AQI'IE 371(6)
`06/13/2016
`
`GROUP ART UNIT ATTORNEg DOCKET
`. KBM-14409/US-13/CO
`
`RULE
`
`APPLICANTS
`AKER BIOMARINE ANTARCTIC AS, Stamsund, NORWAY;
`
`INVENTORS
`
`Inge Bruheim, Volda, NORWAY;
`Snorre Tilseth, Bergen, NORWAY;
`Daniele Mancinelli, Orsta, NORWAY;
`
`** CONTINUING DATA *************************
`
`This application is a CON of 14/020,162 09/06/2013 PAT 9375453
`which is a CON of 12/057,775 03/28/2008 PAT 9034388
`which claims benefit of 60/920,483 03/28/2007
`and claims benefit of 60/975,058 09/25/2007
`and claims benefit of 60/983,446 10/29/2007
`and claims benefit of 61/024,072 01/28/2008
`
`** FOREIGN APPLICATIONS *************************
`
`** |F REQUIRED, FOREIGN FILING LICENSE GRANTED **
`06/22/2016
`
`
`
`3 Yes BN0
`Foreign Prioriiy ciaimed
`
`35 USC 119(a-d) conditions met :I Yes BNO
`Verified and
`/DEBB|E K WARE/
`Acknowledged
`ExamIner's SIgnature
`
`Allowance
`D Met after
`
`WS—
`
`STATE OR
`COUNTRY
`
`SHEETS
`DRAWINGS
`
`TOTAL
`CLAIMS
`
`INDEPENDENT
`CLAIMS
`
`NORWAY
`
`1 9
`
`20
`
`2
`
`ADDRESS
`
`Casimir Jones, SC.
`2275 DEMING WAY, SUITE 310
`MIDDLETON, WI 53562
`UNITED STATES
`
`BIOEFFECTIVE KRILL OIL COMPOSITIONS
`
`FILING FEE FEES: Authority has been given in Paper
`RECEIVED No.
`to charge/credit DEPOSIT ACCOUNT
`for following:
`
`3 1-17 Fees (Processmg EXt- 0“ “me
`:l 1.18 Fees (Issue)
`
`II All Fees
`
`31.16 Fees (Filing)
`
`:l Other
`
`:l Credit
`
`BIB (Rev. 05/07).
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0412
`
`page 0412
`
`

`

`Connecting via Winsock to STN at pto—stn on port 23
`
`
`Welcome to STN International! Enter x:X
`
`LOGINIDzssspt189dxw
`
`
`PASSWORD:
`
`
`
`
`TERMINAL (ENlER l, 2, 3, OR ?):2
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`* Welcome to STN International
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`*
`
`\EWS
`
`1
`
`JAN 29
`
`Instructor—led and on—demand STN training options available
`from CAS
`
`STN Express 8.6 Now Available
`JAN 11
`2
`3 MAR 23 Enhanced Coverage of Latin America (AR, MX)
`Patent Index
`
`\EWS
`
`4 APR 15
`
`
`
`JSPATFULL/USPAT2 Now Include Corporate Patent Aoplicant
`Information
`
`
`
`in Derwent World
`
`
`
`
`
`
`
`.AX 22 Coun:ry Coverage in Derwent World Patent Index Extended to
`Include Turkey
`.AX 28 Partner with CAS :0 help shape the future of CAS products!
`ajor Update to GBFULL Improves Quality of Full Text
`JJl 2
`
`
`illionth Small Molecule Added to CAS REGISTRY
`JJl 7
`100
`
`SEP 15 New Version of Em:ree Introduces over 800 New Terms to
`Embase on Classic STN and New STN
`
`
`
`
`
`
`
`5
`
`6
`7
`8
`9
`
`0
`1
`
`
`
`
`
`
`
`NOV 25 Change to PI field in CAplus records
`
`JAN 11 Pa:entPak Now available to STN Express 8.6 and STN on the
`Web customers
`
`\EWS l5 MAR 23
`
`\EWS
`\EWS
`
`\EWS
`
`\EWS
`\EWS
`\EWS
`\EWS
`
`\EWS
`\EWS
`
`
`
`\EWS l2
`
`\EWS l3
`
`\EWS l4
`
`\EWS
`\EWS
`
`\EWS
`
`6
`7
`
`8
`
`
`
`
`
`
`
`
`
`
`
`JAN 11 CAolus Family of Files Updated with New Data to Support
`Pa:entPak in STN
`The Derwent World Patents Index (DWPI): Latest Manual Code
`JAN 14
`Revision is now live
`
`
`
`FER 9
`Em:ree in Classic STN Updated for 2016 with Additional
`Thesaurus Fields and Expanded Terminology
`
`
`CHEMLIST Content Expanded wi:h the Addition of Information
`from Vermont
`
`
`
`
`APR 26 Da:a Quality Improved in CNFJLL and FRFULL
`JUN 16 Ea:es: New STN Release Now Available
`
`
`
`
`JUN 24 May 2016 Update :0 Emtree in STN Provides Expanded
`
`Terminology for Biomedical and Pharmacological Searchers
`
`
`
`
`
`\EWS EXPRESS 21 MAR 2016 CURRENT WINDOWS VERSION IS V8.6,
`
`
`
`
`AND CURRENT DISCOVER bI-E IS DATED 21 MAR 2016.
`
`STN Operating Hours Plus Helo Desk Availability
`Welcome Banner and News Items
`
`
`
`\EWS {OURS
`\EWS
`.OGIN
`
`
`
`\EWS TRAINING Find ins:ructor—led and self—directed training opportunities
`
`
` En:er NEWS fol’owed by :he item number or name to see news on that
`soecific topic.
`
`
`
`All use of STN is subject to the provisions of the STN customer
`agreement. This agreement limits use to scientific research. Use
`for software development or design,
`implementation of commercial
`gateways, or use of CAS and STN data in the building of commercial
`products is prohibited and may result in loss of user privileges
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0413
`
`page 0413
`
`

`

`and other penalties.
`
`**************STNColumbus
`
`
`bI
`
`
`
`.E 'HOME' ENIE
`RED AI 21:06:46 ON 09 JUL 2016
`
`‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k‘k
`
`=>
`ice
`index bioscie
`
`ESS NOI AUTHORIZED
`PI
`.E 'WPIDS' ACC
`J.
`
`PI
`
`HORIZED
`.E 'WP
`INDEX' ACCESS NOI AUI
` EARS
`COST IN U.S. DOL
`
`
` ESI
`bU..
`
`
` I AIED COSi
`
`
`
`
`
`
`
`
`
`
`
`
`
`SINCE bILE
`
`ENTRY
`0.27
`
`TOTAL
`
`SESSION
`0.27
`
`
`
`
`
`
`
`
`
`
`EA, AVARSTR,
`ADISNEWS, AGRICO
`DEX 'ADISCTI, ADISINSIGiT,
`RIOSIS, EIOTECHAES,
`
`
`
`
`
`
`
`
`
`zA—VTR, CIN, CROPB, CROPJ, DDFB,
`QIOTECHDS, QIOTECIVO, CA3A, CAPLUS, CEA
`
`
`
`
`
`
`
`
`DDbU, DGENE, DISSABS, DRJGB, DRUGU, ? RAL,
`a EASE, ESRIORASE, FOMAD,
`
`
`
`
`FROSTI, FSTA, GENRANK,
`IFIA..,
`.' ENTERED AI 21:06:59 ON 09 JJL 2016
`
`
`
`
`
`46 bILES IN _HE bILE LIST IN SININDLX
`
`
`
`
`
`
`Enter SE. DE.AIL ON to see search :erm postings or
`:0 View
`
`
`search error messages tqat display as 0* with SE1 DETAIL Orb.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IN
`
`Ll
`
`=> s kri;l and encpasuI? and phoquolipid and trime:hyl(p)amine and astaxanthin
`
`
`
`0* FI.E ADISNEWS
`
`
`bI.E RIO_ECHA?S
`0*
`
`bI.E RIO_ECHDS
`0*
`0*
`bI.E RIO_ECHNO
`
`
`bI.E CEARA—VIR
`0*
`
`0* FI.E CIN
`0* FI.E FOMAD
`0* FI.E FROSTI
`0*
`bI.E KOSMEI
`
`0* FI.E NTIS
`0* FI.E PASCAL
`
`
`42 bI.ES SEARCiED
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`0 bI.ES HAVE ONE OR MORE ANSWERS,
`
`
`QUE KRILL AND ENCPASUE? AND PHOSPHOLIPID AND TRIMETHYL(P) AMIVE AND ASTAXA
`NTHIN
`
`
`
`
`
`46 bILES SEARCHED IN STNINDEX
`
`
`
`
`
`
`
`s krill(p)oil and phosp
`qolipid? and trimethyl(p)ami1e and astaxadthin
`
`
`
`0* FI.E ADISNEWS
`
`
`
`bI.E EIO_ECHAES
`0*
`
`
`bI.E EIO_ECHDS
`0*
`0*
`bI.E EIO_ECHNO
`
`
`FI-E CAP-JS
`2
`
`
`
`bI-E CEAEA—VIQ
`0*
`
`0* FI.E CIN
`0* FI.E FOMAD
`0* FI-E FROSTI
`
`
`FI.E IFIA T
`2
`
`
`
`30 bILES SEARCiED...
`0*
`bI-E KOSMEI
`
`0* FI-E NTIS
`
`
`0* FI-E PASCAL
`
`bI-E USPA_bUEL
`15
`
`
`bI-E USPA_2
`4
`
`
`
`
`
`
`
`
`4 bILES HAVE
`ONE OR MORE ANSWERS,
`
`
`
`
`
`
`
`
`
`S EARCHED IN STNINDEX
`
`46 bIL.
`
`
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0414
`
`page 0414
`
`

`

`L2
`
`
`
`QUE KRILL(P) OIL AND PHOSPHOLIPID? AND TRIMETHYL(P) AMINE AND ASTAXANTHIN
`
`
`
`
`
`
`
`
`=> file uspat2 usptful; ifiall caplus
`
`
`
`
`IS NOT A VA.ID bILE NAME
`'USPTFU..'
`
`
`
`
`(=>)
`Enter "{ELP bILE NAMES" at an arrow prompt
`for a list of files
`
`:ha: are available.
`If you have requested multiple files, you can
`specify a correc:ed file name or you can enter "IGNORE" to continue
`
`
`accessing tie remaining file names entered.
`
`
`
`ENTER A bILE NAME OR (IGNORE):.
`COST IN U.S. DOLEARS
`
`
`
`EU.. ESTIMATED COST
`
`
`
`
`
`SINCE bILE
`
`ENTRY
`2.91
`
`TOTAL
`
`SESSION
`3.18
`
`
`
`
`
`
`
`
`
`
`
`
`
`FI-E 'JSPAT2' EN.ERED A. 21:08:51 ON 09 JJE 2016
`
`
`
`
`CA INDEXING COPYRIGiT (C) 2016 AMERICAN CiEMICAL SOCIETY (ACS)
`
`FI.E 'IFIALL' EN.ERED A. 21:08:51 ON 09 JJE 2016
`COPYRIGHT (C) 20T6 IFI CLAIMS(R) Patent Services (IFI)
`
`FI-E 'CAP-US' EN.ERED A. 21:08:51 ON 09 JJE 2016
`
`
`
`
`
`
`
`
`
`
`USE IS SUEJECT TO TiE TERMS Ob YOUR STN CJSTOMER AGREEMENT.
`
`
`
`COPYRIGHT (C) 2016 A ERICAN CHEMICAL SOCIETY (ACS)
`
`=> s L2
`L3
`
`8 E2
`
`=> dup rem L3
`
`
`
`PROCESSING COMP-ETED bOR L3
`
`
`3UP REM L3
`L4
`8
`
`
`
`=> d L4 1—8
`
`
`
`
`
`
`(0 DUPLICATES REMOVED)
`
`
`ANSWER 1 OF 8
`2014:304518
`
`
`
`
`
`
`
`
`
`
`USPAT2 on STN
`
`USPATZ
`
`Formulations of water—soluble deriva:ives of vitamin E and compositions
`
`containing same
`
`3romley, Philip J., Fullerton, CA, UNIiLD STATES
`IN
`
`Inc., Walnut, CA, UNITED STATES (U.S. corporation)
`Virun,
`PA
`
`20160531
`32
`JS 9351517
`PI
`JS 2014—14207310
`20140312 (14)
`AI
`JS 2013—61852243
`20130315 (61)
`PRAI
`Jtili:y
`DT
`
`GRANTED
`FS
`LN.CNT 12112
`NCL
`WCEM:
`
`WCES:
`CPCI
`
`L4
`AN
`
`TI
`
`CPC
`
`424/094.100
`426/072.000; 514/458.000; 514/690.000
`A23E0002—52 [I]; A6TK003l—355 [I]; A6IK003l—122 [I]; A6IK003l—202
`[I
`; A6TK003l—355 [I
`, A6TK2300—00; A6TK003l—202 [I],
`A6u<2300—00; A6TK003u—201 [I], A6IK2300—00; A6IK003l—122 [I],
`A6u<2300—00; A6TK003u—05 [I], A6TK2300—00; A6TK003l—59 [I],
`A6T<2300—00
`CPCI—2 A23E0002—52 [I]; A23E0001—30 [I]; A23L0001—3002 [I]; A23L0001—302
`[I
`; A23L0001—304 [I
`; A23L0001—3006 [I]; A23L0001—3008 [I];
`A23E0002—02 [I]; A23E0002—60 [I]; A6TK0009—0095 [I];
`A6u<0009—1075 [I]; A6TK003l—05 [I]; A6IK003l—122 [I];
`A6T<003l—201 [I]; A6TK003l—202 [I]; A6TK003l—355 [I]; A6TK003l—59
`[I
`; A61K0047—36
`[I]; A61K0047—44 [I]; A61K0031—355 [I],
`A6u<2300—00; A6TK003u—202 [I], A6TK2300—00; A6IK003l—201 [I],
`A6u<2300—00; A6TK003u—122 [I], A6TK2300—00; A6TK003l—05 [I],
`A6u<2300—00; A6TK003n—59
`[I], A6TK2300—00
`A23E0002—52 [I]; A6IK003l—122 [I]; A6IK003l—202 [I]; A6TK003l—355
`[I
`
`
`
`
`
`IPC
`
`IPCI
`
`
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0415
`
`page 0415
`
`

`

`IPCI—2 A61<0038—43 [I]; A23L0002—52 [I]; A61K0031—355 [I]; A61K003l—122
`[I]; A61K003l—202 [I]; A23L0001—30 [I]; A23LOOOl—302 [I];
`A23E0001—304 [I]; A23L0002—02 [I]; A23L0002—60 [I]; A6lK003l—05
`[I]; A61K003l—201 [I]; A61K003l—59 [I]; A6lK0009—00 [I];
`A6l<0047—36 [I]; A61K0009—107 [I]; A61K0047—44 [I]
`A23E0002—52 [I]; A61K003l—122 [I]; A61K003l—202 [I]; A6lK0031—355
`[I]
`
`IPCR
`
`
`
`
`ANSWER 2 OF 8
`2013:254433
`
`USPAT2 on STN
`USPAT2
`
`
`
`Reduced fluoride crustacean oil compositions
`3ruheim,
`Inge, Volda, NORWAY
`
`Griinari, Mikko, Espoo, FINLAND
`Remoy, Stig Rune, Fosnavaag, NORWAY
`
`OLYMPIC SEAFOOD AS, NORWAY (non—U.S. corporation)
`
`JS 9068142
`32
`20150630
`JS 2013—13856642
`20130404 (13)
`Division of Ser. No. US 2012—13342664, filed on 3 Jan 2012, Pat. No. US
`
`8557297 Continuation of Ser. No. US 1900—63488, PENDING A 371 of
`International Ser. No. WO 2009—NO322, filed on 14 Sep 2009
`NO 2008—3906
`20080912
`
`GRANTED
`
`Jtili:y
`
`DT
`FS
`LN.CNT 1416
`
`
`
`001/001.000; 530/359.000
`NCEM:
`
`530/350.000; 554/078.000
`NCES:
`; C07<OOl4—43509 [
`C1130003—006 [I]; C07KOOl9—00
`CPCI
`I]; A23LOOOl—3053
`CPCI—2 C1130003—006 [I]; A23LOOOl—0153
`A23EOOOl—33
`[I]; A23LOOOl—3006 [I]; A23LOOOl—3252 [
`A2330009—Ol3 [I]; A23JOOOl—04
`I
`; A23E0001—0152 [I
`C07<OOl4—43509 [I]; C07KOOl9—00
`I]; A23J0003—34 [I
`A2330009—007 [I]; A23D0009—02
`; C1130001—10 [I];
`[I
`; C1130001—025 [I]
`[I]
`; C07<OOl9—00
`I
`C1130003—00
`I]; C07KOOl4—435
`IPCI
`IPCI—2 C07<OOOl—00
`I]; CllB0003—00 [I]; A23LOOOl—015 [I]; A23EOOOl—305
`[I
`; A23E0001—33 [I]; A23LOOOl—30
`[I]; A23LOOOl—325 [I];
`A2330009—Ol3 [I]; A23JOOOl—04
`I
`; C07<OOl4—435 [I]; C07KOOl9—00
`[I
`; A23J0003—34 [I]; A23D0009—007 [I]; A23D0009—02
`[I];
`C1130001—10
`I]; C1130001—02 [I]
`; A2330009—Ol3 [I]; A23D0009—02
`C07<OOOl—00
`I]; A2330009—007
`I
`[I
`; A23J0001—04 [I]; A23J0003—34 [I]; A23LOOOl—015 [I];
`A23EOOOl—30
`I]; A23EOOOl—305
`I
`; A23EOOOl—325 [I]; A23LOOOl—33
`
`[I
`; C07<OOl4—435 [I]; C07K0019—00
`[I]; C1130001—02 [I];
`
`C1130001—10
`I]; C1130003—00 [I]
`
`
`
`CAS INDEXING IS AVAI.ARLE FOR THIS PAlEN_.
`
`
`
`
`
`IPCR
`
`
`
`
`
`
`
`
`
`I]
`[I];
`I];
`];
`];
`C 1130001—104
`
`
`
`I
`
`I
`
`
`
`
`
`
`
`L4
`AN
`
`TI
`IN
`
`PA
`PI
`AI
`RLI
`
`PRAI
`
`NCL
`
`CPC
`
`IPC
`
`L4
`AN
`TI
`
`IN
`
`PA
`PPA
`PI
`AI
`
`RLI
`FI
`
`
`ANSWER 3 OF 8
`IFIA.. COPYRIGiT 2016 IFI on STN
`
`
`14080750
`IFIA..
`
`
`
`
`
`ETiOD FOR PROCESSING CRUSlACEANS .O PRODUCE LOW FLUORIDfi/LOW lRIMElHYL
`A IVE PRODUClS lHfiRfiOb
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`US 2012—342664
`US 20150030751
`US 8557297
`
`3ru1eim Inge (NO); Griinari Mikko (FI); Ervik Jon Reidar
`Rune
`(NO); Remoy Even (NO); Cameron John (NO)
`anssigned or assigned to individual
`(68000)
`Olympic Seafood As; Rimfrost As
`(Probable)
`JS 20150030751
`A1
`20150129
`JS 2012—370324
`20121221
`
`W0 2012—I33004
`20121221
`PCT 371 date
`20140702
`PCT 102(e) date
`20140702
`20120103 CONTINUATION—IN—PART
`20150129
`
`
`
`
`
`
`
`(NO); Remoy Stig
`
`(14)
`
`
`
`8557297
`
`RIMFROST EXHIBIT 1063
`
`RIMFROST EXHIBIT 1063 page 0416
`
`page 0416
`
`

`

`Jtility; Patent Application — First Publication
`CHE ICAL
`APPEICATION
`
`ED
`En:ered STN: 30 Jan 2015
`
`3T
`FS
`
`
`
`
`Eas: Updated on STN: 20 Nov 2015
`25
`
`OF (non—U.S.
`
`
`ENDING A 371 of International
`
`500/359.000;
`
`435/381.000;
`554/084.000
`A23D0009—02
`[I];
`[I];
`[I];
` 30001—104
`C11:
`
`I 2
`
`I 2
`
`A23D000